Abstract
A human in vitro skin explant test was developed by Alcyomics for the prediction of adverse immune reactions and assessment of relative potency. The skin explant test has a unique readout of histological damage, which ranges in severity from grade 0 and I (negative reaction) to grades II, III and IV damage (positive reaction) in human full-thickness skin. The test has been assessed for predicting responses to sensitizers and non-sensitizers, originally tested in the mouse local lymph node assay (LLNA). Results compared with the LLNA gave 95% specificity, 95% sensitivity and 95% concordance with a correlation coefficient of 0.9. Similar specificity and sensitivity were achieved for comparison of results to published human data with a correlation coefficient of 0.91. The test can also identify chemicals mis-classified in the mouse local lymph node assay (LLNA). Results of the skin test correlate with high or low T cell proliferation and IFNγ production, and these assays can be used as in vitro screening tests for compounds. Collectively, the human in vitro skin explant test can provide a robust, reliable and novel approach for characterization of sensitizing activity as a first step in the risk assessment process.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Vogelsang GB, Hess AD, Berkman AW, Tutschka PJ, Farmer ER, Converse PJ, Santos GW. An in vitro predictive test for graft versus host disease in patients with genotypic HLA-identical bone marrow transplants. N Engl J Med. 1985;313:645–50.
Dickinson AM, Sviland L, Dunn J, Carey P, Proctor SJ. Demonstration of direct involvement of cytokines in graft-versus-host reactions using an in vitro human skin explant model. Bone Marrow Transplant. 1991;7:209–16.
Dickinson AM, Wang XN, Sviland L, Vyth-Dreese FA, Jackson GH, Schumacher TN, Haanen JB, Mutis T, Goulmy E. In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens. Nat Med. 2002;8(4):410.
Jarvis M, Schulz U, Dickinson AM, Sviland L, Jackson G, Konur A, Wang XN, Hromadnikova I, Kolb HJ, Eissner G, Holler E. The detection of apoptosis in a human in vitro skin explant assay for graft versus host reactions. J Clin Pathol. 2002;55:127–32.
Ruffin N, Ahmed SS, Osorio LM, Wang XN, Jackson GH, Collin MP, Ekre HP, Chiodi F, Dickinson AM. The involvement of epithelial Fas in a human model of graft versus host disease. Transplantation. 2011;91:946–51.
Wang XN, Haniffa MA, Holtick U, Collin MP, Jackson G, Hilkens CM, Holler E, Edinger M, Hoffmann P, Dickinson AM. Regulatory T-cell suppression of CD8+ T-cell-mediated graft-versus-host reaction requires their presence during priming. Transplantation. 2009;88:188–97.
Dickinson A, Hromadnikova I, Sviland L, Jackson G, Taylor P, Vavrinec J, Sedlacek P, Cermakova M, Stary J, Vitek A, Sajdova J, Proctor S. Use of a skin explant model for predicting GVHD in HLA-matched bone marrow transplants – effect of GVHD prophylaxis. Bone Marrow Transplant. 1999;24:857–63.
Dickinson AM, Sviland L, Carey P, Reid MM, Hamilton PJ, Pearson AJ, Proctor SJ. Skin explant culture as a model for cutaneous graft-versus-host disease in humans. Bone Marrow Transplant. 1988;3:323–9.
Sviland L, Dickinson AM. A human skin explant model for predicting graft-versus-host disease following bone marrow transplantation. J Clin Pathol. 1999;52:910–3.
Sviland L, Dickinson AM, Carey PJ, Pearson AD, Proctor SJ. An in vitro predictive test for clinical graft-versus-host disease in allogeneic bone marrow transplant recipients. Bone Marrow Transplant. 1990;5:105–9.
Lerner KG, Kao GF, Storb R, Buckner CD, Clift RA, Thomas ED. Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. Transplant Proc. 1974;6:367–71.
Chaudhry Q, Piclin N, Cotterill J, Pintore M, Price NR, Chretien JR, Roncaglioni A. Global QSAR models of skin sensitisers for regulatory purposes. Chem Cent J. 2010;4(Suppl 1):S5.
Dimitrov SD, Low LK, Patlewicz GY, Kern PS, Dimitrova GD, Comber MH, Phillips RD, Niemela J, Bailey PT, Mekenyan OG. Skin sensitization: modeling based on skin metabolism simulation and formation of protein conjugates. Int J Toxicol. 2005;24:189–204.
Ashikaga T, Yoshida Y, Hirota M, Yoneyama K, Itagaki H, Sakaguchi H, Miyazawa M, Ito Y, Suzuki H, Toyoda H. Development of an in vitro skin sensitization test using human cell lines: the human Cell Line Activation Test (h-CLAT). I. Optimization of the h-CLAT protocol. Toxicol In Vitro. 2006;20:767–73.
Faulkner L, Martinsson K, Santoyo-Castelazo A, Cederbrant K, Schuppe-Koistinen I, Powell H, Tugwood J, Naisbitt DJ, Park BK. The development of in vitro culture methods to characterize primary T-cell responses to drugs. Toxicol Sci. 2012;127:150–8.
Python F, Goebel C, Aeby P. Assessment of the U937 cell line for the detection of contact allergens. Toxicol Appl Pharmacol. 2007;220:113–24.
Azam P, Peiffer JL, Chamousset D, Tissier MH, Bonnet PA, Vian L, Fabre I, Ourlin JC. The cytokine-dependent MUTZ-3 cell line as an in vitro model for the screening of contact sensitizers. Toxicol Appl Pharmacol. 2006;212:14–23.
Christiansen J, Farm G, Eid-Forest R, Anderson C, Cederbrant K, Hultman P. Interferon-gamma secreted from peripheral blood mononuclear cells as a possible diagnostic marker for allergic contact dermatitis to gold. Contact Dermatitis. 2006;55:101–12.
Dhabhar FS, Satoskar AR, Bluethmann H, David JR, McEwen BS. Stress-induced enhancement of skin immune function: a role for gamma interferon. Proc Natl Acad Sci U S A. 2000;97:2846–51.
Miyazawa M, Ito Y, Yoshida Y, Sakaguchi H, Suzuki H. Phenotypic alterations and cytokine production in THP-1 cells in response to allergens. Toxicol In Vitro. 2007;21:428–37.
Kimber I, Hilton J, Weisenberger C. The murine local lymph node assay for identification of contact allergens: a preliminary evaluation of in situ measurement of lymphocyte proliferation. Contact Dermatitis. 1989;21:215–20.
Zaghi D, Maibach HI. The local lymph node assay compared with the human maximization test as an indicator of allergic potency in humans using patch test clinic populations. Cutan Ocul Toxicol. 2009;28:61–4.
Ahmed SS, Wang XN, Fielding M, Kerry A, Dickinson II, Munuswamy R, Kimber I, Dickinson AM. An in vitro human skin test for assessing sensitization potential. J Appl Toxicol. 2016;36:669–84.
Kvistborg P, Boegh M, Pedersen AW, Claesson MH, Zocca MB. Fast generation of dendritic cells. Cell Immunol. 2009;260:56–62.
Kobayashi T, Ito T, Kawakamo H, Fuzishiro K, Hirano H, Okubo Y, Tsuboi R. Eighteen cases of wheat allergy and wheat-dependent exercise-induced urticarial/anaphylaxis sensitized by hydrolyzed wheat protein in soap. Int J Dermatol. 2015;54(8):302–5.
Lauriere M, Pecquet C, Bouchez-Mahiout I, Snegaroff J, Bayrou O, Raison-Peyron N, Vigan M. Hydrolysed wheat proteins present in cosmetics can induce immediate hypersensitivities. Contact Dermatitis. 2006;54(5):283–9.
Dickinson A, Sviland L, Jackson G, Dunn J, Stephens S, Proctor SJ. Monoclonal anti TNFα suppresses graft versus host disease reactions in an in vitro skin explant model. Cytokine. 1994;6(2):141–6.
Qesari M, Richter A, OgonekJ, Mischak-Weissinger E, Wang XN, Dickinson AM. Cytomegalovirus-Specific T Cells Isolated by IFN-gamma Secretion Assay Do Not Induce Significant Graft-Versus-Host Reactions In Vitro. Transplantation. 2016;100:2352–61.
Ogese MO, Ahmed SS, Alferivic A, Betts CJ, Dickinson AM, Failkner L, French N, Gibson A, Hirschfield GM, Kammuller M, Meng X, Martin SF, Musette P, Norris A, Pirmohamed M, Park BK, Purcell AW, Spraggs CF, Whritenour J, Naisbitt D. New approaches to investigate drug-induced hypersensitivity. Chem Res Toxicol. 2017;30:239–59.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Dickinson, A., Wang, X.N., Ahmed, S. (2017). An In Vitro Human Skin Test for Assessing Adverse Immune Reactions and Sensitization Potential. In: Eskes, C., van Vliet, E., Maibach, H. (eds) Alternatives for Dermal Toxicity Testing. Springer, Cham. https://doi.org/10.1007/978-3-319-50353-0_30
Download citation
DOI: https://doi.org/10.1007/978-3-319-50353-0_30
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-50351-6
Online ISBN: 978-3-319-50353-0
eBook Packages: MedicineMedicine (R0)